Gambia vs Honduras: HIV/AIDS deaths averted by antiretroviral therapy
Gambia
883.72 deaths
in 2024
Honduras
839.71 deaths
in 2024
Gambia rank
77th
Honduras rank
78th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Gambia
- Honduras
How they compare
Gambia currently reports 883.72 deaths against 839.71 deaths in Honduras, a difference of 44.01 deaths.
That makes Gambia's figure about 1.1 times Honduras's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Honduras ahead.
Gambia ranks 77th and Honduras ranks 78th of 157 countries.
Honduras has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Gambia | Honduras | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 59.36 deaths | 578.33 deaths | 518.97 deaths | Honduras |
| 2010s | 595.79 deaths | 1,022 deaths | 426.13 deaths | Honduras |
| 2020s | 789.23 deaths | 855.75 deaths | 66.52 deaths | Honduras |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Gambia or Honduras?
- Gambia, at 883.72 deaths against 839.71 deaths in Honduras as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Gambia and Honduras?
- 44.01 deaths, with Gambia ahead.
- How many years of comparable data are there for Gambia and Honduras?
- 35 years are reported by both, from 1990 to 2024.
- How do Gambia and Honduras rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Gambia ranks 77th and Honduras ranks 78th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.